Epidemiology and Consequences of Fractures

Similar documents
July 2012 CME (35 minutes) 7/12/2016

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck

Disclosures Fractures:

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Balancing the Risks and Benefits of Osteoporosis Treatment: part I: 3 to 5 years treatment

Skeletal Manifestations

Outline. Switching treatment. Evidence from randomized trials. The effects of switching 7/8/2016. When and for whom? Steven Cummings, MD

Misuse of Bisphosphonates. Dr Rukhsana Parvin Associate Professor Department of Medicine Enam Medical College & Hospital

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.

Page 1. Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018? What s New in Osteoporosis

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Osteoporosis Screening and Treatment in Type 2 Diabetes

Osteoporosis Management

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Diagnosis and Treatment of Osteoporosis: What s New and Controversial in ? What s New in Osteoporosis

Beyond BMD: Bone Quality and Bone Strength

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information.

Meta-analysis: analysis:

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

Current and Emerging Strategies for Osteoporosis

Osteoporosis Agents Drug Class Prior Authorization Protocol

Monitoring Osteoporosis Therapy

Osteoporosis: A Tale of 3 Task Forces!

Disclosures D. Black. Bisphosphonates: Background, Efficacy and Recent Controversies. Page 1. Research Funding: Novartis, Merck

Outline Vertebroplasty and Kyphoplasty: Who, What, and When

Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017

Osteoporosis. Overview

Osteoporosis Management in Older Adults

Calcium, Vitamin D and Bisphosphonates: Disclosures. Benefits, Risks and Drug Holiday. Calcium YES or NO? Calcium Bad News!!

Page 1. Current and Emerging Strategies for Osteoporosis. Osteoporosis Warm-Up: Which of the Following is True?

Page 1. Current and Emerging Strategies What s New in Osteoporosis. Osteoporosis. What is Osteoporosis? Traditional Risk Factors for Fracture

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014

This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against

Who cares about fractures! is more important. October 3, 2014 CSIM Workshop Brian Wirzba, MD, FRCPC, FACP Clinical Professor Grey Nuns Hospital

Download slides:

AACE. Orlando Drug Holidays. Disclosures. Advisory boards: Alexion, Amgen, Lilly, Merck, Radius Health

AN OVERVIEW of TREATMENT: WHO and WHEN to TREAT

Current and Emerging Approaches for Osteoporosis

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Drug Intervals (Holidays) with Oral Bisphosphonates

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

John J. Wolf, DO Family Medicine

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Page 1. New Developments in Osteoporosis. What s New in Osteoporosis

Page 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis

Using the FRAX Tool. Osteoporosis Definition

Osteoporosis 2017 Breaking News. Julie L. Carkin, MD The Seattle Arthritis Clinic

11/4/2018. Osteoporosis Update. ACP Oregon Chapter November 9 th, 2018 Sarah Hopkins Providence Medical Group Endocrinology East. No disclosures.

Medicine and the Current Correlation Between Fosamax and Fractures

Presenter: 翁家嫻 Venue date:

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Differentiating Pharmacological Therapies for Osteoporosis

Page 1. Osteoporosis Warm-Up: Which of the Following is True? Diagnosis and Treatment of Osteoporosis: What is New in What s New in Osteoporosis

Osteoporosis Update. Greg Summers Consultant Rheumatologist

Task Force Co-Chairs. Members

Controversies in Osteoporosis Management

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Ghada El-Hajj Fuleihan, MD,MPH.

DISCLOSURES SUNDEEP KHOSLA, M.D.

Osteoporosis: A Tale of 3 Task Forces!

Osteoporosis Case Studies

BONIVA (ibandronate sodium)

OSTEOPOROSIS: AN OPPORTUNITY OR OBLIGATION

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Imaging to Assess Bone Strength and its Determinants

TREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

Fracture=Bone Attack:

Analysis of Clinical Features of Hip Fracture Patients with or without Prior Osteoporotic Spinal Compression Fractures

Hot Topics in Osteoporosis and Fracture Prevention

Long-term Osteoporosis Therapy What To Do After 5 Years?

Dartmouth General Hospital Fracture Liaison Service. Carla Purcell BScN, RN, CMSN(C) Fracture Navigator

ACP Colorado-Evidence Based Management of Osteoporosis

Outline Vertebroplasty and Kyphoplasty: Who, What, and When

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

Changes in Skeletal Systems over the Lifespan. Connie M. Weaver, Ph.D. Purdue University

Reducing the Risk of Fracture in Postmenopausal Women: Guidance for Family Physicians. Please complete the preassessment before the session starts.

Chau Nguyen, D.O. Rheumatologist Clinical Assistant Professor of Internal Medicine at Western University of Health Sciences

Osteoporosis Evaluation and Treatment

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

Talking to patients with osteoporosis about initiating therapy

Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women

Osteoporosis in Men. CME Away India & Sri Lanka March 23 - April 7, 2018

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.

Osteoporosis: current treatment and future prospects. Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Osteoporosis Update. Case 2. Case 1: Monday morning, 8:15

A Review of Bone Health Issues in Oncology

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

Current Issues in Osteoporosis

Setting The setting was primary care. The economic study was carried out in the USA.

A Brief History of Osteoporosis

Marcy B. Bolster, MD Associate Professor of Medicine Division of Rheumatology Endocrine Associates Massachusetts General Hospital

An Update on Osteoporosis Treatments

A Population-Based Study of the Effectiveness of Bisphosphonates at Reducing Hip Fractures among High Risk Women

Updates in Osteoporosis

Pharmacy Management Drug Policy

Beyond BMD: Bone Quality and Bone Strength

Transcription:

Epidemiology and Consequences of Fractures Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Financial Disclosures Advisory Board: Amgen Research Support: Hologic 24July12 1

Outline Fracture incidence Demographic determinants of fracture incidence Age Gender Race Geography Consequences of fracture Temporal trends and the future Osteoporotic fractures: Incidence compared with other diseases U.S. women 55+ Singer A et al Mayo Clinic Proceedings, 2015 24July12 2

Common sites of fracture Spine Hip Wrist Lifetime risks of clinical fractures 50 year old white women (U.S.) Lifetime risk* Hip fracture 17% Wrist fracture 16% Vertebral fracture 16% Any fracture > 50% Breast cancer 15% *Refs: Melton; Black; Kanis 24July12 3

SA11 Prevalence of Osteoporosis in US Major determinants of fracture incidence Demographic: Age Gender Race Geography Previous fracture: discuss under Consequences of Fracture More on risk factors for fracture and fracture prediction: Talk by Dr. Harris later today. 24July12 4

Slide 7 SA11 make a graph? Schwartz, Ann, 6/30/2017

Age and gender are important determinants of fracture incidence Harvey N et al ASBMR Primer Ch 40 2013 Age is Independent of BMD as Risk Factor for Hip Fracture 20 10 Age (yrs) 80 70 60 5-fold increase in fracture probability from age 50 to 80 at same BMD 50 Kanis et al, 2004 0-3 -2-1 0 1 Hip BMD T-score (SD) 24July12 5

Lifetime risks of fracture: Impact of gender Lifetime Risk at Age 50* Fracture Men (%) Women (%) Hip 6 17 Wrist 3 16 Clinical Vert Fx 5 16 Any 16% > 50% * Among Caucasians Osteoporosis in Men 1 in 5 to 6 men over age 50 will suffer osteoporotic fracture 30% of hip fractures worldwide are in men Mortality rates after fracture higher in men than women Treatment rates following fracture are abysmal 24July12 6

Hip fracture incidence by race (California) Sullivan et al 2016 Hip fracture rates vary dramatically by region and country Cauley et al. (2014) Nat. Rev. Endocrinol. 24July12 7

Vertebral Fracture Incidence Worldwide Radiographic fractures. Age standardized. Ballane et al Osteo Intl 2017 Consequences of fracture 24July12 8

Hip fractures are associated with increased morbidity and mortality No longer able to live independently No longer able to get in/out of bath No longer able to walk independently 40% 50% 17% 30% Death within one year Among those independent prefracture Magaziner J. J. Gerontol A Biol Sci Med Sci 2000 Mortality elevated after hip fracture Women Men Haentjens et al JAMA 2010 24July12 9

Limited Activity Days Post Fracture: Postmenopausal Women in FIT Consequences of fracture Fink et al. Osteo Intl 2003 Impact of Vertebral Fractures 20% excess mortality in 5 yrs after fracture Deformity & height loss Acute & chronic pain Pulmonary dysfunction Diminished quality of life: loss of self-esteem, sleep disorder, depression, loss of independence 24July12 10

Length of stay and costs for hospitalization Singer et al Mayo Clinic Proceedings 2015, High medical costs for hip and for other fractures Hip $25,519 Excess direct costs for Medicare patients with nonvertebral fractures Costs for year after fracture (1999-2006) Expressed in 2006 dollars Pike et al PharmacoEconomics 2012 24July12 11

Consequence of fracture: Increased risk of another fracture History of any fracture: 1.5-3.0 fold greater risk of fracture True for any fracture type even traumatic fractures especially strong for men Mostly independent of BMD vanstaa, Osteop Int 2002;13:624-9 Meta-analysis: Klotzbuecher, JBMR 2000;15:721; Kanis Osteop Int 2004 Vertebral fractures dramatically increase risk of future fracture 4x risk of more vert fxs 2x risk of other fractures (vanstaa, Osteop Int 2002) Women with clinical diagnosis of vertebral fracture have 5-15% 5 yr hip fracture risk! Not in FRAX 24July12 12

Existing Vertebral Fracture Predictive of Future Vertebral Fracture Independent of BMD Previous Vert Frx No Vert Frx 0.2 1.7 1.0 2.3 3.4 5.8 Low BMD Mid BMD High BMD Ross 1991 0 1 2 3 4 5 6 Risk of New Vertebral Fractures (% / yr) Effect of prevalent radiographic vertebral fracture on non-vertebral fracture risk Absolute fracture risk (%) 6 5 4 3 2 1 0 No vert fx >1 vert fx -2-3 -4 Femoral neck T-score Siris et al, Osteo Int 2007 24July12 13

Trends in Use of Osteoporosis Therapy NYT (6/2/16): Osteoporosis drugs shunned for fear of rare side effects 24July12 14

Osteoporosis medication use to 2004 Brauer et al JAMA 2009 Oral Bisphosphonate Use in the U.S. Declines after 2008 % of 55+ y.o. with 1 prescription in annual federal survey Jha et al JBMR 2015 24July12 15

U.S. Google search activity for Fosamax A = Lawsuit filed against Merck for Fosamax causing osteonecrosis of the jaw. B = Study published associating Fosamax with atrial fibrillation. C = Jury deliberations start for first Fosamax trial. D = ABC World News runs feature segment on Fosamax and atypical femoral fractures. Jha et al JBMR 2015 Treatment with osteoporosis medication during year after fracture Vertebral Hip Balasubramanian et al. J Bone Joint Surg Am 2014 24July12 16

Osteoporosis Medication Use After Hip Fracture U.S. Patients 2002-11 Solomon et al JBMR 2014 Osteoporosis Related Health Services Utilization After First Hip Fracture Women in the United States, 2008 2014 Gillespie & Morin JBMR 2017 24July12 17

Prospects for the Future Hip fracture incidence declining in U.S. Jha et al JBMR 2015 Including California Hip fracture incidence in CA Sullivan et al 2016 24July12 18

Hip Fracture Rates Declining in West, Increasing in East Age-standardized Ballane et al JBMR 2014 Prospects for the Future... Elderly represent fastest growing segment of population Thus, in spite of declining rates in US, total number of fractures expected to increase 24July12 19

World Population: 1990 and 2025 Age range (years) 80+ 1990 71-75 61-65 51-55 41-45 31-35 21-25 11-15 0-5 Men Women 80+ 71-75 61-65 51-55 41-45 31-35 21-25 11-15 0-5 2025 300 200 100 0 100 200 300 Number (000,000) Worldwide Distribution of Hip Fractures in Women: 1990 to 2050 Hip Fractures, x1000 3000 1990 2500 2025 2000 2050 1500 1000 500 0 Women Women N. Am, Europe Mid East, Asia, Latin Am, Africa 24July12 20

Summary Fractures are common Age is a strong determinant of fracture risk, especially for hip and spine Fractures are associated with significant morbidity, excess mortality and costs. Osteoporosis therapy use after hip fracture is <20% in women and <10% in men Age-adjusted fracture incidence is stable or even declining in the US, but total number of fractures will increase due to aging of population Thank you 24July12 21